Septic Arthritis Market Research Report Information: By Diagnosis (Joint Fluid Analysis, Blood Tests, Imaging), Treatment (Antibiotics, Surgery), Indication (Arthritis, Diabetes,), End User (Orthopedic Hospitals, Clinics, Diagnostic Centers) - Forecast till 2030

Market Synopsis of Septic Arthritis Market

The Septic Arthritis Market is anticipated to reach USD 69,448.42 Million by 2030 at 2.10% CAGR during the forecast period 2022-2030.Septic arthritis is a disease caused by a bacterial infection or invasion in the joints leading to inflammation. Symptoms of septic arthritis include redness, heat, and pain in the joints reducing their movement. It is caused by bacteria, viruses, fungi, and parasites. Diabetes, osteoarthritis, gout, rheumatoid arthritis, joint trauma and poor immune function are major risk factors for septic arthritis.

The septic arthritis market is driven by an increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, availability of cost effective treatment and extensive research and development activities in internal medicine. There is an increasing demand for the new drugs for the treatment of septic arthritis which further fuels the growth of the septic arthritis market.

Bacterial resistance to commonly used antibiotics such as vancomycin may restrain for the growth of the septic arthritis market. Fierce competition among key market players acts as a barrier for the new entrants in the septic arthritis market.

Segments    

The septic arthritis market is segmented on the basis of diagnosis, treatment, indication, and end user.

On the basis of diagnosis, septic arthritis market is segmented into joint fluid analysis, blood tests, imaging and others. Imaging is further segmented into X-ray, ultrasonography, MRI, and CT scan.

On the basis of treatment, the septic arthritis market is segmented into antibiotics, aspiration of the joint, surgery, and others. Surgery is further segmented into arthrotomy and arthroscopy.

On the basis of indication, the septic arthritis market is segmented into arthritis, hip or knee prosthesis, poor immune function, joint surgery, and others.

On the basis of end user, the septic arthritis market is segmented into orthopedic hospitals, clinics, pharmaceutical companies, and others.

FIGURE 1: Global Septic Arthritis Market by Region, 2016 (%)

Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation

Research Methodology

Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation Regional Analysis of theSeptic Arthritis Market        

America is the largest market for septic arthritis owing to the rising prevalence of septic arthritis in the U.S., According to the Center for Disease Control and Prevention, an estimated 78 million (26%) U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. Furthermore, arthritis prevalence was the highest among people 65 years and older, women, and obese population.

Europe is the second largest septic arthritis market owing to the rising prevalence of rheumatoid arthritis in European countries and availability of funds for research and development activities.

The market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing geriatric population, rising prevalence of chronic disease such as diabetes, and obesity, and changing lifestyles of the people. Diabetes is one of the major problems further creating opportunities for the septic arthritis market growth.

The Middle East & Africa also show a steady rise in the market owing to increasing prevalence of diabetes and other chronic diseases.

Key Players in the Septic Arthritis Market    

Some of the key players in the septic arthritis market are Lupin Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Johnson & Johnson Inc. (U.S.), and Pfizer (U.S.).

Intended Audience

• Arthritis Drug Manufacturers


• Arthritis Drug Suppliers


• Medical Research Laboratories


• Research and Development (R&D) Companies


• Market Research and Consulting Service Providers


• Potential Investors

 

Report Scope:

Report Attribute/Metric	Details
Market Size	2030: USD 69,448.42 Million
CAGR	2.10% (2022-2030)
Base Year	2021
Forecast Period	2022-2030
Historical Data	2020
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Diagnosis, Treatment, Indication, and End user
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Lupin Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Johnson & Johnson Inc. (U.S.), and Pfizer (U.S.)
Key Market Opportunities	New product launches and R&D Amongst major key Players
Key Market Drivers	·  Increasing prevalence of chronic diseases ·  Availability of cost effective treatment ·  Extensive research and development activities in internal medicine ·  Increasing demand for the new drugs for the treatment of septic arthritis

 

Frequently Asked Questions (FAQ) :